OncoTherapy Science announces stop of phase III study on COMPETE-PC, its pancreatic cancer-directed cocktail vaccine C01

Clinical efficacy is not sufficiently higher as compared to control group.

OncoTherapy Science press release, December 20, 2013

Most popular posts: